These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

370 related items for PubMed ID: 7630698

  • 21. Antibody response to the protein antigens of "Salmonella typhi" during typhoid infection and following vaccination with a live oral typhoid vaccine Ty21a.
    Chau PY, Tsang RS.
    Dev Biol Stand; 1983; 53():29-31. PubMed ID: 6873471
    [Abstract] [Full Text] [Related]

  • 22. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Schwartz E.
    N Engl J Med; 2009 Nov 26; 361(22):2191-2; author reply 2192-3. PubMed ID: 19950412
    [No Abstract] [Full Text] [Related]

  • 23. Immune response of infants and preschool children to typhoid vaccine given intradermally or subcutaneously.
    Mohandas V, Cherian T, Sridharan G, Simoes EA, Pereira SM, John TJ.
    BMJ; 1989 Jan 21; 298(6667):162-3. PubMed ID: 2493838
    [No Abstract] [Full Text] [Related]

  • 24. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN, Kurlova VI, Yanisker GY, Lavrovskaya VM, Blant ME, Negina YP.
    Acta Microbiol Acad Sci Hung; 1974 Jan 21; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract] [Full Text] [Related]

  • 25. Re: typhoid fever vaccines: systematic review and meta-analysis of randomised clinical trials.
    Arya SC, Agarwal N.
    Vaccine; 2008 Jan 17; 26(3):291. PubMed ID: 18082292
    [No Abstract] [Full Text] [Related]

  • 26. Vaccines against typhoid fever.
    Guzman CA, Borsutzky S, Griot-Wenk M, Metcalfe IC, Pearman J, Collioud A, Favre D, Dietrich G.
    Vaccine; 2006 May 01; 24(18):3804-11. PubMed ID: 16278037
    [Abstract] [Full Text] [Related]

  • 27. Advances in vaccines for typhoid fever.
    Gupta A, Jalla S, Sazawal S, Bhan MK.
    Indian J Pediatr; 1994 May 01; 61(4):321-39. PubMed ID: 8002060
    [No Abstract] [Full Text] [Related]

  • 28. Clinical experience with typhoid vaccine in Thailand.
    Sarasombath S.
    Southeast Asian J Trop Med Public Health; 1988 Sep 01; 19(3):471-4. PubMed ID: 3064324
    [Abstract] [Full Text] [Related]

  • 29. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Arya SC, Agarwal N.
    N Engl J Med; 2009 Nov 26; 361(22):2191; author reply 2192-3. PubMed ID: 19940305
    [No Abstract] [Full Text] [Related]

  • 30. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever.
    Klugman KP, Gilbertson IT, Koornhof HJ, Robbins JB, Schneerson R, Schulz D, Cadoz M, Armand J.
    Lancet; 1987 Nov 21; 2(8569):1165-9. PubMed ID: 2890805
    [Abstract] [Full Text] [Related]

  • 31. Typhim Vi vaccine against typhoid fever: a clinical trial in Kenya.
    Mirza NB, Wamola IA, Estambale BA, Mbithi E, Poillet M.
    East Afr Med J; 1995 Mar 21; 72(3):162-4. PubMed ID: 7796767
    [Abstract] [Full Text] [Related]

  • 32. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. A preliminary report.
    Acharya IL, Lowe CU, Thapa R, Gurubacharya VL, Shrestha MB, Cadoz M, Schulz D, Armand J, Bryla DA, Trollfors B.
    N Engl J Med; 1987 Oct 29; 317(18):1101-4. PubMed ID: 3657877
    [Abstract] [Full Text] [Related]

  • 33. Immunogenicity of a new Salmonella Typhi Vi polysaccharide vaccine--vax-TyVi--in Cuban school children and teenagers.
    Azze RF, Rodríguez JC, Iniesta MG, Marchena XR, Alfonso VM, Padrón FT.
    Vaccine; 2003 Jun 20; 21(21-22):2758-60. PubMed ID: 12798615
    [Abstract] [Full Text] [Related]

  • 34. The role of epidemiology in the introduction of vi polysaccharide typhoid fever vaccines in Asia.
    Acosta CJ, Galindo CM, Ochiai RL, Danovaro-Holliday MC, Page AL, Thiem VD, Park JK, Park E, Koo H, Wang XY, Abu-Elyazeed R, Ali M, Albert MJ, Ivanoff B, Pang T, Xu ZY, Clemens JD.
    J Health Popul Nutr; 2004 Sep 20; 22(3):240-5. PubMed ID: 15609776
    [Abstract] [Full Text] [Related]

  • 35. Efficacy of Salmonella typhi Vi capsular polysaccharide vaccine in South Africa.
    Arya SC.
    Vaccine; 1997 Feb 20; 15(2):244. PubMed ID: 9066045
    [No Abstract] [Full Text] [Related]

  • 36. A review of the current status of enteric vaccines.
    Levine MM, Noriega F.
    P N G Med J; 1995 Dec 20; 38(4):325-31. PubMed ID: 9522876
    [Abstract] [Full Text] [Related]

  • 37. Persistence of antibody titres three years after vaccination with Vi polysaccharide vaccine against typhoid fever.
    Tacket CO, Levine MM, Robbins JB.
    Vaccine; 1988 Aug 20; 6(4):307-8. PubMed ID: 3188615
    [Abstract] [Full Text] [Related]

  • 38. Virulence and immunogenicity of galactose-resistant variants of Salmonella typhi Ty21a.
    Saxena M, Percheson PB, Di Fabio JL.
    J Infect Dis; 1993 Aug 20; 168(2):522-3. PubMed ID: 8336003
    [No Abstract] [Full Text] [Related]

  • 39. Why are typhoid vaccines not recommended for epidemic typhoid fever?
    Taylor DN, Levine MM, Kuppens L, Ivanoff B.
    J Infect Dis; 1999 Dec 20; 180(6):2089-90. PubMed ID: 10558978
    [No Abstract] [Full Text] [Related]

  • 40. Vivotif--a 'magic shield' for protection against typhoid fever and delivery of heterologous antigens.
    Gentschev I, Spreng S, Sieber H, Ures J, Mollet F, Collioud A, Pearman J, Griot-Wenk ME, Fensterle J, Rapp UR, Goebel W, Rothen SA, Dietrich G.
    Chemotherapy; 2007 Dec 20; 53(3):177-80. PubMed ID: 17347563
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.